A New Technology Hiding in Covid Vaccines
Prognosis: Misconception
Bloomberg
4.1 • 838 Ratings
🗓️ 23 December 2020
⏱️ 17 minutes
🧾️ Download transcript
Summary
The approved COVID-19 vaccines developed by Moderna and the Pfizer and BioNTech partnership use genetic material called messenger RNA to effectively transform the body’s own cells into vaccine factories. This approach is a first for vaccines. It relies on decades of clinical research into whether messenger RNA technology can be used to treat a broad range of ailments, from cancer to the seasonal flu. Naomi Kresge explores whether the validation of this breakthrough technology during COVID-19 could bring about a whole new field of medicine.
See omnystudio.com/listener for privacy information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | What could you do if your data was working for you and not against you? With Bloomberg delivering |
| 0:07.3 | enterprise data directly to your systems, you get easy access to the details you want, optimized for |
| 0:14.1 | higher level analysis, and financial data experts committed to helping you maximize your every move. |
| 0:24.0 | Our data is made for more, so you can show the world what you're made of. Visit Bloomberg.com slash enterprise data to learn more. |
| 0:30.5 | Welcome to Prognosis. I'm Laura Carlson. It's day 284 since coronavirus was declared a global pandemic. Today's main story, |
| 0:41.6 | the first vaccines against COVID-19 aren't just a landmark in the fight against the pandemic. |
| 0:49.9 | They're also the stepping stone for an unconventional technology that could one day defeat other ailments that have alluded doctors, from cancer to heart disease. |
| 1:03.3 | But first, here's what happened in virus news today. |
| 1:18.5 | UK Prime Minister Boris Johnson imposed tougher regulations across a swath of England in an effort to rein in the mutant strain of coronavirus that has spread across the country. |
| 1:25.8 | South Korea and the Philippines moved to temporarily suspend U.K. flights, while Japan is |
| 1:32.1 | strengthening entry regulations for people traveling from Britain. Air travel from Britain to France |
| 1:38.3 | resumed after a two-day halt, although with eligibility restrictions and a virus testing requirement. |
| 1:46.0 | Italy uncovered the new COVID-19 strain in an infected person, with no apparent links to the UK. |
| 1:54.6 | Canada's public health authorities approved Moderna's coronavirus vaccine, |
| 1:59.7 | the second to be licensed in the country that secured |
| 2:02.7 | more doses per person than any other. Approval of the Moderna shot will allow Canada to expand |
| 2:10.1 | its vaccination campaign beyond inoculation sites and urban centers. Canada's northern regions |
| 2:17.2 | have specifically requested |
| 2:19.1 | Moderna doses due to its less cumbersome refrigeration requirements. |
| 2:25.1 | Pfizer and partner Bio-NTech agreed to double the supply of their COVID-19 vaccine to the U.S. |
| 2:32.7 | The new agreement brings the total number of doses to be delivered to the U.S. to 200 million, |
| 2:39.2 | the companies announced Wednesday. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.